• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫:苦木苦味素和青蒿琥酯(青蒿素半琥珀酸酯衍生物)的体外相互作用。

Plasmodium falciparum: in vitro interaction of quassin and neo-quassin with artesunate, a hemisuccinate derivative of artemisinin.

机构信息

Institute of Life Sciences, Nalco Square, Chandrasekhar Pur, Bhubaneswar 751 023, Orissa, India.

出版信息

Exp Parasitol. 2010 Apr;124(4):421-7. doi: 10.1016/j.exppara.2009.12.007. Epub 2009 Dec 29.

DOI:10.1016/j.exppara.2009.12.007
PMID:20036657
Abstract

Quassia amara L. (Family Simaroubaceae) is known to have several medicinal properties including the activity against malaria. An HPLC method was employed for purification of the biologically active quassinoids; quassin (Q) and neo-quassin (NQ), further characterized by MALDI-TOF analyses. Purified Q, NQ and the crude bark extract (S1) along with artesunate (AS) were studied for their in vitro anti-plasmodial activity. The in vivo toxicity studies at intraperitoneal doses with higher concentrations of the crude bark extract (S1) in Balb/C mice ruled out the apprehension of toxicity. Interaction studies between the test compounds among themselves (Q+NQ) and individually with artesunate (AS+Q, AS+NQ), were carried out in vitro at four ratios (1:5, 1:2, 2:1 and 5:1) on chloroquine sensitive (MRC-pf-20) and resistant (MRC-pf-303) strains of Plasmodium falciparum. The crude bark extracts of Q. amara exhibited higher P. falciparum inhibitory activity (IC(50)=0.0025 microg/ml) as compared to that of the isolated compounds, quassin (IC(50)=0.06 microg/ml, 0.15 microM), neo-quassin (IC(50)=0.04 microg/ml, 0.1 microM) and also to the positive control, artesunate (IC(50)=0.02 microg/ml, 0.05 microM). The in vitro drug interaction study revealed the compounds, quassin and neo-quassin to be additive to each other. At lower ratios, artesunate was found to be a potential combination partner with both the compounds. It was interesting to note that none of the combinations exhibited antagonistic interactions. This phenomenon offers the opportunity for further exploration of novel therapeutic concentrations and combinations.

摘要

苦木(Family Simaroubaceae)已知具有多种药用特性,包括抗疟疾活性。采用 HPLC 法对具有生物活性的苦木苦味素进行纯化;苦木素(Q)和新苦木素(NQ),进一步通过 MALDI-TOF 分析进行表征。对纯化的 Q、NQ 和粗树皮提取物(S1)以及青蒿琥酯(AS)进行了体外抗疟原虫活性研究。在腹腔内给予更高浓度的粗树皮提取物(S1)的体内毒性研究排除了毒性的担忧。在体外,在四种比例(1:5、1:2、2:1 和 5:1)下,对测试化合物相互之间(Q+NQ)以及与青蒿琥酯(AS+Q、AS+NQ)之间的相互作用进行了研究在氯喹敏感(MRC-pf-20)和耐药(MRC-pf-303)株疟原虫上。与分离的化合物苦木素(IC50=0.06μg/ml,0.15μM)、新苦木素(IC50=0.04μg/ml,0.1μM)和阳性对照青蒿琥酯(IC50=0.02μg/ml,0.05μM)相比,苦木的粗树皮提取物对疟原虫的抑制活性更高(IC50=0.0025μg/ml)。体外药物相互作用研究表明,化合物苦木素和新苦木素相互之间为相加作用。在较低的比例下,青蒿琥酯被发现是与这两种化合物的潜在组合伙伴。有趣的是,没有一种组合表现出拮抗相互作用。这种现象为进一步探索新的治疗浓度和组合提供了机会。

相似文献

1
Plasmodium falciparum: in vitro interaction of quassin and neo-quassin with artesunate, a hemisuccinate derivative of artemisinin.恶性疟原虫:苦木苦味素和青蒿琥酯(青蒿素半琥珀酸酯衍生物)的体外相互作用。
Exp Parasitol. 2010 Apr;124(4):421-7. doi: 10.1016/j.exppara.2009.12.007. Epub 2009 Dec 29.
2
In vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosa.体外和体内评估金合欢的抗疟活性。
Malar J. 2011 May 2;10:112. doi: 10.1186/1475-2875-10-112.
3
Antiplasmodial activity of extracts and quassinoids isolated from seedlings of Ailanthus altissima (Simaroubaceae).臭椿(苦木科)幼苗提取物及苦木素类化合物的抗疟活性
Phytother Res. 2003 Jun;17(6):675-7. doi: 10.1002/ptr.1336.
4
Quassinoid constituents of Quassia amara L. leaf herbal tea. Impact on its antimalarial activity and cytotoxicity.苦木科植物叶片药茶的苦木素成分。对其抗疟活性和细胞毒性的影响。
J Ethnopharmacol. 2009 Oct 29;126(1):114-8. doi: 10.1016/j.jep.2009.07.037. Epub 2009 Aug 7.
5
Simalikalactone D is responsible for the antimalarial properties of an Amazonian traditional remedy made with Quassia amara L. (Simaroubaceae).西玛卡内酯D是一种由苦木科苦木制成的亚马逊传统药物具有抗疟特性的原因。
J Ethnopharmacol. 2006 Nov 3;108(1):155-7. doi: 10.1016/j.jep.2006.04.017. Epub 2006 Apr 27.
6
Delaumonones A and B, new antiplasmodial quassinoids from Laumoniera bruceadelpha.地劳莫诺内酯A和B,来自布鲁斯地劳莫尼亚树的新型抗疟苦木素类化合物。
Chem Pharm Bull (Tokyo). 2009 Aug;57(8):867-9. doi: 10.1248/cpb.57.867.
7
Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C.从糙叶斑种草中分离得到的两种倍半萜内酯的抗寄生虫活性
J Ethnopharmacol. 2012 May 7;141(1):411-7. doi: 10.1016/j.jep.2012.03.002. Epub 2012 Mar 13.
8
Antiulcerogenic effects and possible mechanism of action of Quassia amara (L. Simaroubaceae) extract and its bioactive principles in rats.苦木提取物及其生物活性成分在大鼠中的抗溃疡作用及可能的作用机制。
Afr J Tradit Complement Altern Med. 2011 Oct 2;9(1):112-9. doi: 10.4314/ajtcam.v9i1.16. eCollection 2012.
9
Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria.马达加斯加哈伦加那茎皮提取物对滴虫和疟疾的抗原生动物活性。
J Ethnopharmacol. 2008 May 22;117(3):507-11. doi: 10.1016/j.jep.2008.02.019. Epub 2008 Mar 10.
10
Antimalarial and safety evaluation of extracts from Toddalia asiatica (L) Lam. (Rutaceae).苦木科鸦胆子属植物苦木(Toddalia asiatica (L.)Lam.)的抗疟及安全性评价。
J Ethnopharmacol. 2013 Jan 30;145(2):587-90. doi: 10.1016/j.jep.2012.11.034. Epub 2012 Dec 1.

引用本文的文献

1
Repositioning Brusatol as a Transmission Blocker of Malaria Parasites.将 Brusatol 重新定位为疟疾寄生虫的传播阻断剂。
ACS Infect Dis. 2024 Oct 11;10(10):3586-3596. doi: 10.1021/acsinfecdis.4c00434. Epub 2024 Oct 1.
2
Antiplasmodial natural products: an update.抗疟天然产物:更新。
Malar J. 2019 Dec 5;18(1):404. doi: 10.1186/s12936-019-3026-1.
3
Andrographolide: A Novel Antimalarial Diterpene Lactone Compound from Andrographis paniculata and Its Interaction with Curcumin and Artesunate.穿心莲内酯:来自穿心莲的新型抗疟二萜内酯化合物及其与姜黄素和青蒿琥酯的相互作用。
J Trop Med. 2011;2011:579518. doi: 10.1155/2011/579518. Epub 2011 Jun 7.
4
In vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosa.体外和体内评估金合欢的抗疟活性。
Malar J. 2011 May 2;10:112. doi: 10.1186/1475-2875-10-112.